Unlocking Powerful Biology: OGB21502 is a Tetra- Specific Drug (GLP-1 X GCG X FGF21 X IL1RA) to Treat NASH & Liver Fibrosis

Time: 11:30 am
day: Seminar A- AM tracks


  • Novel protein-protein conjugation technology, which enables the facile development of multi-modalities, multi-targeting drugs
  • Can IL-1 blocking make synergy in improving fibrosis and metabolism?
  • Preclinical findings recommend transitioning towards the clinical stage in 2024